Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Nicotinamide Riboside Supplementation In Progressive Multiple SclerosisRecruiting
NCT05740722Phase 2Updated Jan 11, 2024
Sponsor: Haukeland University Hospital
Multiple Sclerosis · Progressive Multiple Sclerosis
Norway
A Study of Ocrelizumab in Participants With Primary Progressive Multiple SclerosisCompleted
NCT01194570Phase 3Updated Jan 10, 2024
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Primary Progressive
United States, Australia, Austria, Belgium, Brazil +24 more
Ex-Plissit Model Based Counseling on Sexual Function and Sexual SatisfactionCompleted
NCT06199219NAUpdated Jan 10, 2024
Sponsor: Necmettin Erbakan University
MS (Multiple Sclerosis) · Sexual Dysfunctions · Counseling
Turkey (Türkiye)
RELAXaHEAD for Headache Patients (Phase II)Completed
NCT05466682NAUpdated Jan 10, 2024
Sponsor: NYU Langone Health
Migraine · Headache · Multiple Sclerosis · Insomnia
United States
Neurofilament Light Chain as Diagnostic and Prognostic Marker in naïve Multiple Sclerosis PatientsUnknown
NCT06197841N/AUpdated Jan 9, 2024
Sponsor: Assiut University
Role of Neurofilment in Diagnosis of Multiple Sclerosis
Egypt
Efficacy of Square- Stepping Exercises in Individuals With Multiple SclerosisCompleted
NCT05682963NAUpdated Jan 8, 2024
Sponsor: Pamukkale University
Multiple Sclerosis
Turkey (Türkiye)
A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in BrazilUnknown
NCT03087136N/AUpdated Jan 8, 2024
Sponsor: Pontificia Universidade Católica do Rio Grande do Sul
Multiple Sclerosis
Brazil
Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis PatientsUnknown
NCT05902429Phase 4Updated Jan 8, 2024
Sponsor: Pontificia Universidade Católica do Rio Grande do Sul
Multiple Sclerosis, Relapsing-Remitting
Brazil
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis PatientsUnknown
NCT06195644Phase 1Updated Jan 8, 2024
Sponsor: Cairo University
Cortical Excitability · Multiple Sclerosis
Egypt
Biomarkers of aHSCTUnknown
NCT06195800N/AUpdated Jan 8, 2024
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Multiple Sclerosis, Relapsing-Remitting
United Kingdom
Multiple Sclerosis Prediction and Monitoring of Progression StudyUnknown
NCT05685784NAUpdated Jan 8, 2024
Sponsor: University Hospital, Ghent
Progressive Multiple Sclerosis
Belgium
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of FranceUnknown
NCT02887781N/AUpdated Jan 5, 2024
Sponsor: University Hospital, Brest
Tuberous Sclerosis Complex
France
MS Spinal Mobilisation StudyCompleted
NCT05090709NAUpdated Jan 5, 2024
Sponsor: Edinburgh Napier University
Multiple Sclerosis
United Kingdom
RIPC on Activity, Fatigue and Gait in MSCompleted
NCT03967106NAUpdated Jan 5, 2024
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Multiple Sclerosis
United Kingdom
Ischemic Preconditioning, Exercise Tolerance and Multiple SclerosisCompleted
NCT03153553NAUpdated Jan 3, 2024
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Multiple Sclerosis
United Kingdom
Understanding Magnetic Resonance Imaging in Multiple SclerosisCompleted
NCT03872583NAUpdated Jan 3, 2024
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Clinically Isolated Syndrome
Germany
tDCS to Enhance Cognitive Training in Multiple SclerosisWithdrawn
NCT04261556NAUpdated Jan 3, 2024
Sponsor: University of Milano Bicocca
Multiple Sclerosis, Relapsing-Remitting
Italy
Finding Patterns In Clinical Study Experiences of Multiple Sclerosis PatientsNot Yet Recruiting
NCT05503524N/AUpdated Jan 2, 2024
Sponsor: Power Life Sciences Inc.
Multiple Sclerosis
TRPMS to Improve Mobility and Depression in Multiple SclerosisWithdrawn
NCT04578041NAUpdated Dec 28, 2023
Sponsor: NYU Langone Health
Multiple Sclerosis
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple SclerosisCompleted
NCT03737851Phase 2Updated Dec 22, 2023
Sponsor: AbbVie
Multiple Sclerosis (MS)
United States, Canada
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple SclerosisCompleted
NCT03737812Phase 2Updated Dec 21, 2023
Sponsor: AbbVie
Multiple Sclerosis (MS)
United States, Canada
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis PatientsUnknown
NCT05735067N/AUpdated Dec 19, 2023
Sponsor: German University in Cairo
Multiple Sclerosis
Egypt
Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)Terminated
NCT04465448N/AUpdated Dec 18, 2023
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
White Matter Hyperintensity · Multiple Sclerosis
France
PatientSpot Formerly Known as ArthritisPowerUnknown
NCT03840928N/AUpdated Dec 13, 2023
Sponsor: Global Healthy Living Foundation
Rheumatoid Arthritis · Ankylosing Spondylitis · Fibromyalgia · Gout
United States
Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5TCompleted
NCT04707144N/AUpdated Dec 13, 2023
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Multiple Sclerosis
France

Previous page Next page